Form D Explorer

Form C-AR — Cytex Therapeutics, Inc.

0001665160-23-001128 · filed 2023-05-01

Offering

Target
—
Maximum
—
Security type
—
Price per security
—
Deadline
—
Oversubscription
—

Issuer

Name
Cytex Therapeutics, Inc.
CIK
1943908
Entity
Corporation
Jurisdiction
DE
Address
2609 N. DUKE STREET, SUITE 303A
DURHAM, NC 27704
Phone
—

Most recent fiscal year financials

Total assets
$530,603
Cash
—
Short-term debt
$193,580
Long-term debt
$490,492
Revenues
$1,052,219
COGS
$731,921
Taxes paid
—
Net income
$-621,726

Same issuer's Form D filings

View original on SEC EDGAR.